Cannabinoid-Based Patch for Fibromyalgia, Other Chronic Pain Is Ready for Release

The first batch of the Chronic Pain CBIS Transdermal Patch will soon be released, offering a cannabinoid-based alternative to people around the globe who self-medicate for fibromyalgia and other chronic pain conditions, Cannabis Science has announced.

In November 2016, the company announced the development of two new medications for pain relief in people with fibromyalgia, neuropathy, diabetic nerve pain, back strains, and other pain-related conditions. These pain relievers correspond to transdermal adhesive patches that deliver a certain dose of medication into the bloodstream by absorption through the patient’s skin.


This site uses Akismet to reduce spam. Learn how your comment data is processed.